Clinical Outsourcing Cost Management and Decision Making Survey

Online Survey: Clinical Outsourcing Cost Management and Decision Making

Before You Begin:

In exchange for fully completing the survey, you will receive our complete survey findings -- provided we use your survey data.
We will blind your responses. Neither your name nor company will be linked to any data.
Where necessary, estimates and rounded figures are fine.
After you submit your answers, we will contact you with any necessary follow-up questions.

Your Information

Name
Company
Title
Email
Phone

Working with CROs

1. Which of the following CROs are currently considered to be preferred service providers at your company? Please select all that apply.

AAI Development Services
Cato Research
Chiltern International
Clinical Trial Management Services (CTMS)
Covance
CroMedica
Fisher
I3 Research
ICON
INC Research
Ingenix
Inveresk Research Group
Kendle
MDS Pharma Services
Omnicare Clinical Research
Parexel
Pharmaco International
PharmaNet
PPD
PRA International
Premier Research
Promedica International
Quintiles
Other (Please specify: )
Other (Please specify: )
Other (Please specify: )

2. Please assess your company’s overall experience in working with each of the following CROs. Select “N/A” if your company has not worked with the CRO within the past few years.

CRO	N/A	Poor	Below Average	Average	Above Average	Excellent
AAI Development Services
Cato Research
Chiltern International
Clinical Trial Management Services (CTMS)
Covance
CroMedica
I3 Research
ICON
INC Research
Ingenix
Inveresk Research Group
Kendle
McKesson Bioservices
MDS Pharma Services
Omnicare Clinical Research
Parexel
Pharmaco International
PharmaNet
PPD
PRA International
Promedica International
Quintiles
Scirex
Other - please specify:
Other - please specify:
Other - please specify:

3. Please rate the following criteria according to their importance in choosing which CRO to work with for a typical clinical trial at your company.

Criteria	Not Important	Somewhat Important	Important	Very Important	Critical
Size of CRO
CRO’s track record of success/reputation
Offers full range of services
CRO has previously worked with the drug in question
CRO is a preferred service provider
Depth of therapeutic area knowledge/experience
Level of expertise in conducting trials in a given development phase
CRO’s presence in the country where trial is to take place
Has professional, well-trained monitors/CROs
Maintains open communication
Reasonable fees for services
Responds quickly to inquiries
Flexibility (i.e., willingness to make changes during projects)
Provides good overall protocol design
Professionalism of personnel
Meets deadlines/delivers projects on time
Project management skills
Demonstrated ability to deliver patients
Overall quality of services/reputation for quality
Technical personnel turnover
Other - please specify:
Other - please specify:
Other - please specify:

4. Please indicate which CRO has the greatest expertise in each of the following therapeutic areas. Please respond only for those therapeutic areas that your company specializes in or that you have specific knowledge of. Please answer “N/A” if there is no clear-cut leader for a specific therapeutic area.

Therapeutic Area	CRO with Most Expertise
Autoimmune
Cardio & Thrombosis
CNS/Psychology
Dermatology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Lifestyle
Musculoskeletal
Oncology
Respiratory
Urology
Women's Health

5. Please indicate which CRO has the greatest expertise in each of the following development phases. Please answer “N/A” if there is no clear-cut leader for a specific development phase.

Development Phase	CRO with Most Expertise
Phase 1
Phase 2
Phase 3a
Phase 3b
Phase 4

6. Please indicate which CRO has the greatest expertise in conducting each of the following types of Phase 3 trials. Please answer “N/A” if there is no clear-cut leader for a specific type of Phase 3 trial.

Type of Phase 3 Trial	CRO with Expertise
Blinded, randomized trials
Open trials
Factorial trials
Crossover trials